The pathogenesis of Cushing's disease, which is caused by pituitary corticotroph adenoma, remains to be studied. Secreted angioinhibitory factor thrombospondin-1 (TSP-1) is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions and is associated with platelet aggregation, angiogenesis and tumorigenesis. We Furthermore, RNA-immunoprecipitation associates miR-449c with lncTHBS1 suggesting that lncTHBS1 might be a negative regulator of miR-449c. Taken together, this study has demonstrated that lncTHBS1 might function as competing endogenous RNA for miR-449c, which could suppress the development of Cushing's disease.
hypercortisolism. 6 Approximately one-to two-third(s) of corticotroph adenomas possess somatic mutations in the 14-3-3 protein binding motif of ubiquitin specific peptidase 8 (USP8), a deubiquitinating enzyme gene. 7, 8 Mutations in USP8 may be associated with some of the clinical features of Cushing's disease such as tumour aggressiveness and ACTH hypersecretion. 9, 10 However, the symptoms of Cushing's disease are similar to other conditions and often remain unrecognized, especially in individuals diagnosed with diabetes, hypertension or depression. 11 In fact, the mortality rates in patients with untreated Cushing's disease are reported to be up to nine times higher those of the general population. 12, 13 Pituitary adenomectomy is generally performed in the first-line treatment of
Cushing's disease, however, pituitary adenomas often recur after remission. 2 Therefore, more effective therapeutic and diagnostic approaches are needed to improve the survival prospects of patients with Cushing's disease.
Thrombospondin-1 (TSP-1) is a matricellular protein first found in human plasma and widely expressed in diverse tissue. 14 TSP-1 is a multi-domain glycoprotein that is encoded by the THBS1 gene and involved in cell-to-cell and cell-to-matrix interactions, in particular, it is associated with platelet aggregation, angiogenesis and tumorigenesis. [15] [16] [17] Using RNA sequencing (RNA-Seq), the transcriptome of 13 cases of CD and five normal human pituitaries (NHPs) were analysed in our previous study. 18 Marked downregulation of the TSP-1 encoding gene was identified in Cushing's disease. TSP-1 has been demonstrated to have a complicated role in human cancer and to exert stimulatory and inhibitory effects in different types of tumours. TSP-1 is known as an inhibitor of proliferation in endothelial cells 19 and induces apoptosis, 20 and suppresses the cell cycle. 21 TSP-1 is under-expressed in various tumours such as colorectal cancer, 22 clear cell renal carcinoma. 23 The upregulation of TSP-1 can suppress tumour growth in stroma 24 and oesophageal squamous cell carcinoma. 25 Moreover, it was reported that activated somatostatin receptor subtype2 (sst2) and bone morphogenetic protein 4 (BMP4) can also suppress the growth of solid tumours, such as in pancreatic and cervical cancers, via the induction of TSP-1. 26, 27 Interestingly, use of an sst2 analog and BMP4
can also inhibit corticotroph tumour cells and ACTH secretion as well. 28, 29 In addition, through the activation of TGF-beta, TSP-1 may inhibit angiogenesis and tumour growth in multiple cancers. 30 It is also known that the downregulation of the TGF beta signalling pathway and activation of the TGF pathway may decrease the secretion of ACTH and tumour cell proliferation in pituitary corticotrophinomas. 31, 32 However, TSP-1 may, in contrast, be involved in the promotion of tumorigenesis in various cancers such as gastric cancer and human melanoma. 33, 34 TSP-1 induced by TGFB1 is reported to promote the migration of oral squamous cell carcinoma and stimulate the expression of matrix metalloproteinases (MMPs) through integrin signalling. 35 However, the decreased expression of TSP-1 and its cause in Cushing's disease remains to be elucidated.
TSP-1 is proposed to influence the vascular endothelial growth factor (VEGF) pathway by binding to a high-affinity receptor CD47
and disrupting its association with VEGF receptor 2, which in turn downregulates the pro-angiogenic signals downstream of VEGF.
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Ki67, VEGF and matrix metalloproteinase-9 (MMP9) are among the markers normally used to identify the biochemical characteristics of Cushing's disease. [37] [38] [39] [40] [41] MicroRNAs (miRNAs) are short non-coding RNA molecules with 44 LncRNA CCAT2 has recently been found to be significantly upregulated in pituitary adenomas tissues. 45 Loss-and gain-of-function assays showed that CCAT2 positively regulated pituitary adenoma cell proliferation, migration and invasion, and interacted with PTTG1 to promote its stability.
To investigate dysregulated lncRNAs and miRNAs in Cushing's disease we selected miR-449c and lncTHBS1 and compared their expression in ACTH-secreting adenoma and normal pituitary tissue.
Northern blot analysis, luciferase assay and RNA-immunoprecipitation assay were used to determine the reciprocal relationship between miR-449c and lncTHBS1. We also investigated the expression of TSP-1 in ACTH-secreting adenoma and its effects on the expression of POMC, VEGF, Ki67 and MMP9.
| MATERIAL S AND ME THODS

| Human tissue samples and cell culture
Human pituitary tumour samples were obtained by transsphenoidal surgery from 33 patients with Cushing's disease. Normal human pituitaries (NHP) (n = 7) were obtained from fresh autopsy specimens.
This study was approved by the Ruijin Hospital Ethics Committees and written informed consent was obtained from all patients. HEK-293T
and the mouse AtT20 pituitary corticotroph tumour cell line were obtained from the American Tissue Type Collection (ATCC, Manassas, VA, USA). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM, GIBCO, Carlsbad, CA, USA) with 10% foetal bovine serum (FBS), 2 mmol/L L-glutamine and 100 μg/mL penicillin/streptomycin in a humidified incubator with 5% CO 2 at 37°C.
| Plasmid construction
TSP-1 and negative controls were obtained from GenePharma following the manufacturer's instructions. All primers used in the study can be found in Table 1 . The pRenilla-TK vector was used as an internal control for the dual-luciferase assay. Cells were grown to 60%-70% confluence then seeded into six-well plates 24 hours before infection. The cells in each well were transfected with 1 mL of culture medium containing 10 μL of lentivirus (1×10 9 TU/ml) and incubated for 72 hours, the infection rate was observed using a fluorescence microscope(Olympus, Center Valley, PA, USA).
Western blotting was used to confirm effective transfection.
| Immunohistochemistry
Tissues were fixed in 4% paraformaldehyde for at least 24 hours, de- 50°C for 2 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The primers used in the study can be found in Table 1 . Relative expression of mRNAs, lncTHBS1and miR-449c was calculated using the 2 −ΔΔCT method and normalized to GAPDH and U6, respectively. (1:1000, 10375-2-AP, Proteintech) and VEGF (1:1000, MAB293, R&D Systems) followed by incubating with horseradish peroxidaseconjugated secondary antibody for 2 hours at room temperature.
Protein bands were visualized using an enhanced chemiluminescence Amersham TM ECL Plus Western blotting detection system (GE Healthcare, Amersham, UK).GAPDH was used as internal loading control.
| Cell viability assays and colony formation test
To determine cell viability, AtT20 cells were seeded into 96-well plates (2000 cells/well) and incubated for 24 hours until they were attached. Cell viability was determined using a Cell Counting Kit-8
(Dojindo Laboratories, Kumamoto, Japan) following the manufacturer's instructions. Colony formation was determined by culturing AtT20 cells in 6-well plates (10 3 cells/well) in DMEM culture medium containing 10% FBS, which was replaced every 4-5 days. After 21 days, colonies were fixed for 20 minutes in 4% paraformaldehyde in PBS containing 4% sucrose and then stained with 0.005% crystal violet for 30 minutes. After washing in PBS, colonies were counted using an inverted microscope.
| Cell apoptosis analysis (Annexin V assay)
Apoptosis was assessed by flow cytometry using an AnnexinV-FITC apoptosis detection kit (Beyotime, Shanghai, China). After harvesting, cells were washed twice with cold PBS and then stained for 10 minutes at room temperature in 1 mL Annexin V binding buffer with 10 μL of PI solution (100 µg/ml; Sigma, Israel) and 5 μL of 
| Cell migration and invasion assays
| ELISA assay
ACTH ELISA kit (EK-001-21, Phoenix Pharmaceuticals) was used to detect the level of ACTH. Corticosterone ELISA kit (ALPCO, 55-CORMS-E01) was used to detect the level of corticosterone. Briefly, the culture media of AtT20 cells was collected from each well after overexpressing miR-449c or TSP-1 for 48 hours for further measurement. Then, the kit was used following the manufacturer's instruction. Each experimental group was analysed six times and the experiments were repeated independently three times.
| In vivo xenograft tumour model
Six-week-old nu/nu male mice were inoculated subcutaneously with 
| Northern blot analysis
Total RNA (20 μg) was prepared using TRIzol reagents (Life Technologies) was denatured with formaldehyde and loaded on to agarose gel containing 1.2% formaldehyde. After electrophoresis, the RNA was transferred to a nylon membrane and fixed with a UV crosslinker. The membrane was probed with a digoxigenin-labelled lncTHBS1 oligonucleotide probe with the following sequence:
5′-tgcacggggtgggatcgcggcaccgcactctggta-3′ at a concentration of 10 pmol/L, overnight at 42°C. Blots were processed using a Brightstar Detection Kit (Ambion Inc, Austin, TX, USA). A GADPH probe (5′-ggtgctaagcagttggtggtgcaggaggcattgct-3′) was used as an internal control. 
| RNA-immunoprecipitation assays
| Dual-luciferase assay
The lncTHBS1 promoter was amplified from human genomic DNA and then subcloned into a pGL3 vector (Promega) to construct qRT-PCR (n = 3; *P < 0.05, **P < 0.01, ***P < 0.001 vs control). D, TSP-1 effects on adrenocorticotropic hormone (ACTH) secretion was detected by ELISA assay. E, MTT assay showed that overexpression TSP-1 decreased cell growth rates. F, Colony formation was assessed under a microscope. (n = 3, *P < 0.05, **P < 0.01). G, Cell apoptosis was determined by flow cytometry. Mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001 
| Statistical analysis
Comparisons were analysed using a two-tail unpaired Student's Table 2 .
| TSP-1 suppresses tumorigenicity in vitro and in vivo
To further investigate the influence of TSP-1 on cell proliferation, migration and invasion we transfected a murine AtT20 pitui- Figure 4F ). TSP-1, MMP-9, VEGF expression were detected by Western Blot ( Figure 4G ). Ki67, MMP-9
and VEGF levels are reduced. Taken together, these results indicate that overexpressing TSP-1 decreases tumour growth in nude mice.
| TSP-1 inversely correlates with miR-449c expression in human ACTH-secreting pituitary adenomas
The influence of miR-449c expression on the regulation of TSP-1 was 
| lncTHBS1 and TSP-1 correlate through targeting by miR-449c and a reciprocal negative regulation existed between miR-449c and lncTHBS1
On the basis of bioinformatics website prediction and in connection with previous findings from whole transcriptome analysis of adenoma tissue from patients with Cushing's disease and normal pituitary tissue, 18 proposed that the aberrantly expressed lncTHBS1 may play an important role for the regulation of TSP-1 in Cushing's disease. Firstly, we confirmed that the expression of lncTHBS1 mRNA was lower in pituitary ACTH-secreting (n = 33) adenoma compared with normal pituitary tissue (n = 7) ( Figure 7A ). Furthermore, the correlation analysis confirmed a relationship between lncTHBS1 
| D ISCUSS I ON
ACTH-secreting pituitary adenomas, originating from pituitary corticotroph cells, are related to substantial morbidity and cause adrenal hypercortisolaemia, which is often referred to as Cushing's disease. 47 The pathogenesis of Cushing's disease is obscure and it remains difficult to treat successfully. [48] [49] [50] The present study aimed In the present study, we also assessed protein levels of Ki67, patients with Cushing's disease, which indicated increased cell proliferation. In previous studies, the expression of Ki67, VEGF and MMP9 appear to be elevated in Cushing's disease. 38, 40 Ki-67 is a marker of cell proliferation and is found to occur at significantly higher levels in invasive compared with non-invasive adenomas. 51 The growth factor VEGF can induce endothelial cell proliferation and the permeabilization of blood vessels, promote cell migration, inhibit apoptosis and is actively involved in the angiogenesis, vasculogenesis and endothelial cell growth of several cancers including colorectal cancer 52 and ovarian granulosa cell tumour. 53 In pituitary adenomas, VEGF expression is well preserved and might contribute to the vascular supply of tumours. 54 . The inhibitory effect of TSP-1 on VEGF-mediated angiogenesis is also proposed to involve the TSP-1 receptor CD36 and endothelial cell apoptosis pathways. 55 A recent study evaluating MMP9, the pituitary tumour transforming gene (PTTG), high mobility group A 2 (HMGA2) and Ki-67 in recurrent and non-recurrent ACTHsecreting pituitary tumours, has found that high levels of MMP9 are associated with a greater reoccurrence and a shorter recurrence-free interval. 38 The same study found that PTTG, HMGA2
and Ki-67 expression were not significantly different between recurrent and non-recurrent ACTH-secreting pituitary tumours. In
Positive correlation between TSP-1 and lncTHBS1 expression. lncTHBS1 targets miR-449c by directly binding to a miRNA response element. A, The expression of lncTHBS1 mRNA in CD (n = 33) and normal pituitary tissue (n = 7). B, Correlation analysis of the relationship between lncTHBS1 expression and TSP-1 level. C, Northern blot assays were used to detect lncTHBS1 expression in CD. D, Schematic representation of the predicted binding sites for miR-449c, and the site mutagenesis design for the reporter assay. E, The relative luciferase activities were inhibited in the HEK-293T cells transfected with the reporter vector lncTHBS1-WT, but not with the reporter vector lncTHBS1-Mut. F, miR-449c expression decreased lncTHBS1 expression, and inhibition of miR-449c enhanced lncTHBS1 expression in the HEK-293T cells. G, lncTHBS1 expression decreased miR-449c expression whereas inhibition of lncTHBS1 increased miR-449c expression in HEK-293T cells. H, miR-449c was identified in the lncTHBS1 complex. miR-NC and miR-449c cell lysates were used for RNA-IP with antiAgo2 antibody. Cells transfected with miR-449c mimics or miR-NC, followed by qRT-PCR to detect lncTHBS1. **P < 0.01 the present study, VEGF and MMP9 appeared to be upregulated and located in the cytoplasm whereas Ki67 was upregulated and located in the nucleus. 62 In this study
we confirmed a correlation analysis between lncTHBS1 and TSP-1 expression and that miR-449c expression decreased lncTHBS1 expression, whereas, lncTHBS1 expression decreased miR-449c
expression. In addition, miR-449c was identified in an lncTHBS1 complex using RNA-IP with anti-Ago2 antibody. RNA-IP is a novel strategy that exploits the involvement of Argonaute proteins in the translational repression complex associated with microRNA. 63 The technique involves the immunoprecipitation of whole miRsilencing complexes containing miRs and associated target mRNAs. 64 Our results indicate a positive correlation between TSP-1 and lncTHBS1 expression and demonstrate that lncTHBS1 
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